Financial News

Vertex taps California startup for $700M gene-editing deal

Vertex has developed cystic fibrosis therapies and is working with other partners on CRISPR-Cas9 systems as well as messenger RNA, or MRNA, therapies with Moderna Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback